CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...